Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 466 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2006
Liu J, Malkani G, Mankani G, Shi X, Meyer M, Cunningham-Runddles S, Ma X, Sun ZSheng.  2006.  The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock.. Infect Immun. 74(8):4750-6.
Liu J, Malkani G, Mankani G, Shi X, Meyer M, Cunningham-Runddles S, Ma X, Sun ZSheng.  2006.  The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock.. Infect Immun. 74(8):4750-6.
Kathpalia VP, Mussak EN, Chow SS, Lam PH, Skelley N, Time M, Markelewicz RJ, Kanduc D, Lomas L, Xiang Z et al..  2006.  Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures.. J Dermatol. 33(5):309-18.
Kathpalia VP, Mussak EN, Chow SS, Lam PH, Skelley N, Time M, Markelewicz RJ, Kanduc D, Lomas L, Xiang Z et al..  2006.  Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures.. J Dermatol. 33(5):309-18.
Anand VK, Kacker A, Orjuela AF, Huang C, Manarey C, Xiang JZ.  2006.  Inflammatory pathway gene expression in chronic rhinosinusitis.. Am J Rhinol. 20(4):471-6.
Liu J, Ma X.  2006.  Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1.. J Biol Chem. 281(28):19188-95.
Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L.  2006.  Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.. Endocrinology. 147(1):44-50.
Chung EY, Kim SJung, Ma XJing.  2006.  Regulation of cytokine production during phagocytosis of apoptotic cells.. Cell Res. 16(2):154-61.
Murray HW, Xiang Z, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.. Am J Trop Med Hyg. 74(6):1013-5.
Murray HW, Xiang Z, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.. Am J Trop Med Hyg. 74(6):1013-5.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.. Infect Immun. 74(7):4370-4.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.. Infect Immun. 74(7):4370-4.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Visceral Leishmania donovani infection in interleukin-13-/- mice.. Infect Immun. 74(4):2487-90.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Visceral Leishmania donovani infection in interleukin-13-/- mice.. Infect Immun. 74(4):2487-90.
2005
Morris RP, Nguyen L, Gatfield J, Visconti K, Nguyen K, Schnappinger D, Ehrt S, Liu Y, Heifets L, Pieters J et al..  2005.  Ancestral antibiotic resistance in Mycobacterium tuberculosis.. Proc Natl Acad Sci U S A. 102(34):12200-5.
Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, Liu J, Ma X.  2005.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.. Infect Immun. 73(7):3903-11.
Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, Liu J, Ma X.  2005.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.. Infect Immun. 73(7):3903-11.
Ehrt S, Guo XV, Hickey CM, Ryou M, Monteleone M, Riley LW, Schnappinger D.  2005.  Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.. Nucleic Acids Res. 33(2):e21.
Torroella-Kouri M, Ma X, Perry G, Ivanova M, Cejas PJ, Owen JL, Iragavarapu-Charyulu V, Lopez DM.  2005.  Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.. Cancer Res. 65(22):10578-84.
Hisert KB, MacCoss M, Shiloh MU, K Darwin H, Singh S, Jones RA, Ehrt S, Zhang Z, Gaffney BL, Gandotra S et al..  2005.  A glutamate-alanine-leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic diGMP.. Mol Microbiol. 56(5):1234-45.
Hisert KB, MacCoss M, Shiloh MU, K Darwin H, Singh S, Jones RA, Ehrt S, Zhang Z, Gaffney BL, Gandotra S et al..  2005.  A glutamate-alanine-leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic diGMP.. Mol Microbiol. 56(5):1234-45.
Kim S, Chung EY, Ma X.  2005.  Immunological consequences of macrophage-mediated clearance of apoptotic cells.. Cell Cycle. 4(2):231-4.
Liu J, Guan X, Ma X.  2005.  Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.. J Biol Chem. 280(26):24347-55.
Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, Jimenez V, Ma X.  2005.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.. Curr Immunol Rev. 1(2):119-137.
Veazey RS, Springer MS, Marx PA, Dufour J, Klasse PJohan, Moore JP.  2005.  Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.. Nat Med. 11(12):1293-4.